| Chemical | Toxicity Endpoint Type | Endpoint Description | Endpoint Value | Sample Size | Life Cycle Stage | Study Duration | Type |
|---|---|---|---|---|---|---|---|
| EPN | TOX-MORT - dose-response data | percent survival versus controls | decreased @ 12 ug/g (82%); 36 ug/g (77%); 108 ug/g (70%) | 10/group | Embryo | 7 or 14 d | Toxicity Factor Datasets |
| EPN | TOX-Non-Repro-Sublethal - cellular/biochemical effects | brain weight, acetylcholinesterase activity, neurotoxic esterase activity versus controls | decreased @ 12, 36, 108 ug/g | 10/group | Embryo | 7 or 14 d | Toxicity Factor Datasets |
| EPN | TOX-Non-Repro-Sublethal - cellular/biochemical effects | brain protein content versus controls | decreased @ 108 ug/g | 10/group | Embryo | 7 or 14 d | Toxicity Factor Datasets |
| EPN | TOX-Non-Repro-Sublethal - cellular/biochemical effects | plasma alkaline phosphatase, aspartate aminotransferase, cholinesterase activities, and uric acid | decreased @ 36 (cholineserase only), 108 ug/g | 12/group | Embryo | 14 d | Toxicity Factor Datasets |
| EPN | TOX-REPRO - development | embryo weight and length, % normal survivors versus controls | decreased @ 12, 36, 108 ug/g | 12/group | Embryo | 14 d | Toxicity Factor Datasets |
| EPN | TOX-MORT - dose-response data | % surviving to hatch versus controls | decreased @ 12 ug/g (48%), 36 ug/g (29%), 108 ug/g (0%) | 12/group | Hatchling | to hatch | Toxicity Factor Datasets |
| EPN | TOX-Non-Repro-Sublethal - cellular/biochemical effects | plasma cholinesterase activity, hemoglobin and uric acid content | decreased @ 12, 36 ug/g | 12/group | Hatchling | to hatch | Toxicity Factor Datasets |
| EPN | TOX-Non-Repro-Sublethal - cellular/biochemical effects | brain weight, protein content, acetylcholinesterase and neurotoxic esterase versus controls | decreased @ 12, 36 ug/g | 12/group | Hatchling | to hatch | Toxicity Factor Datasets |
